Patients with CNS inflammation may have intrathecal production of polyspecific antibodies against antigens such as MOG which are more accessible during active inflammation, as seen in MS.15, 16 Indeed, all studies to date have identified CSF‐restricted MOG‐IgG in some patients with MS. This evidence concerns the gene MOG and myeloid sarcoma.